Forskning
Udskriv Udskriv
Switch language
  1. Region Hovedstaden
  2. Publikationer
  3. Ductal carcinoma in situ
  4. Citationsformater
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Ductal carcinoma in situ

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Harvard

Skaar, M, Langhans, L, Mertz, B & Kroman, N 2018, 'Ductal carcinoma in situ', Ugeskrift for Laeger, bind 180, nr. 38.

APA

Skaar, M., Langhans, L., Mertz, B., & Kroman, N. (2018). Ductal carcinoma in situ. Ugeskrift for Laeger, 180(38).

CBE

Skaar M, Langhans L, Mertz B, Kroman N. 2018. Ductal carcinoma in situ. Ugeskrift for Laeger. 180(38).

MLA

Skaar, Marica o.a.. "Ductal carcinoma in situ". Ugeskrift for Laeger. 2018. 180(38).

Vancouver

Skaar M, Langhans L, Mertz B, Kroman N. Ductal carcinoma in situ. Ugeskrift for Laeger. 2018 sep. 17;180(38).

Author

Skaar, Marica ; Langhans, Linnea ; Mertz, Birgitte ; Kroman, Niels. / Ductal carcinoma in situ. I: Ugeskrift for Laeger. 2018 ; Bind 180, Nr. 38.

Bibtex

@article{ea410fa0ddbf40a9ad6cabae402776e7,
title = "Ductal carcinoma in situ",
abstract = "Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.",
author = "Marica Skaar and Linnea Langhans and Birgitte Mertz and Niels Kroman",
year = "2018",
month = sep,
day = "17",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "38",

}

RIS

TY - JOUR

T1 - Ductal carcinoma in situ

AU - Skaar, Marica

AU - Langhans, Linnea

AU - Mertz, Birgitte

AU - Kroman, Niels

PY - 2018/9/17

Y1 - 2018/9/17

N2 - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

AB - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

M3 - Tidsskriftartikel

C2 - 30259839

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 38

ER -

ID: 56652673